Boston Scientific (BSX) Total Debt Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 19.06% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -5.76% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -2.49% |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | -5.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.48% |
| Dec 31, 2025 | 6.42% |
| Sep 30, 2025 | 6.57% |
| Jun 30, 2025 | -90.73% |
| Mar 31, 2025 | 6.50% |
| Dec 31, 2024 | 18.06% |
| Sep 30, 2024 | 22.32% |
| Jun 30, 2024 | 16.77% |
| Mar 31, 2024 | 17.92% |
| Dec 31, 2023 | 176.24% |
| Sep 30, 2023 | 3.67% |
| Jun 30, 2023 | 0.90% |
| Mar 31, 2023 | 156.33% |
| Dec 31, 2022 | -63.65% |
| Sep 30, 2022 | -5.51% |
| Jun 30, 2022 | -1.50% |
| Mar 31, 2022 | -61.37% |
| Dec 31, 2021 | -0.85% |
| Sep 30, 2021 | 19,229.79% |
| Jun 30, 2021 | 28,365.63% |